Bausch + Lomb announced the results of a large-scale clinical study of its newest intraocular lens (IOL), the enVista® Envy™. Data published in the authoritative American Journal of Ophthalmology confirms that this lens provides patients with continuous high-quality vision – from distance to near – with minimal visual disturbances after cataract surgery.
Study Details: A Technology Comparison
The large-scale study was designed to objectively evaluate the performance of the new enVista Envy lens, which belongs to the “Extended Depth of Focus” (EDOF) class, compared to the well-established monofocal enVista lens.
- Scale: The study involved 501 cataract patients.
- Methodology: Participants were divided into two groups. One group was implanted with the new Envy lens, and the other received the standard monofocal lens, which primarily corrects distance vision.
- Goal: To determine how effectively the new EDOF lens improves vision at intermediate and near distances while maintaining the same high standard of distance vision clarity.
Key Results: What the Envy Lens Demonstrated
The study results revealed clear advantages of the enVista Envy intraocular lens.
- Superiority at Intermediate and Near Distances: The Envy lens showed a statistically significant advantage in visual quality at 66 cm (working on a computer, tablet) and 40 cm (reading a book). At the same time, distance visual acuity remained at the same high level as with the monofocal lens.
- Complete Spectacle Independence: Patients with the Envy lenses demonstrated better binocular vision without glasses at all distances – far, intermediate, and near. This signifies a substantial improvement in quality of life after surgery.
- Minimal Visual Disturbances: A key finding was the minimal difference in contrast sensitivity (an indicator of visual quality in low-light conditions) between the Envy lens and the monofocal lens. This indicates that the lens provides excellent vision without significant side effects, such as glare or halos, which are sometimes associated with other premium lenses.
- High Safety Profile: The study confirmed that the Envy lens is safe. There were no reports of serious complications or secondary surgeries directly related to its optical properties.
“The results of this study fully reflect what I observe in my clinical practice,” commented the study’s lead author, Dr. Mitchell Schultz. “I have long trusted the enVista platform and see Envy as an excellent option for patients who want a lens that provides a full range of vision with minimal visual disturbances. It is a predictable and effective outcome.”
Significance for Patients and Surgeons
The publication of this data is a significant event in ophthalmology. Built on a proven and reliable platform, the enVista Envy lens offers ophthalmic surgeons a predictable and safe tool not just for cataract removal, but for achieving maximum spectacle independence after surgery. For patients, this means the ability to return to an active lifestyle with comfortable vision at any distance.